Mammographic breast density in women with premature ovarian failure: A prospective analysis

Menopause

Volumn 21, Issue 9, 2014, Pages 933-937

  Benetti Pinto, Cristina Laguna ^a   Brancalion, Maria Fernanda ^a   Assis, Luisa H ^a   Tinois, Eduardo ^b   Giraldo, Helena P D ^a   Cabello, César ^a   Yela, Daniela A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Institute of Security and Technology in Radiation   (Brazil)

Author keywords

Breast cancer risk; Breast density; Hormone therapy; Percentage of mammographic density; Premature ovarian failure

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; BREAST DENSITY; CANCER RISK; COMPUTER ASSISTED DIAGNOSIS; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENARCHE; NULLIPARA; ONSET AGE; PREGNANCY; PREMATURE OVARIAN FAILURE; BREAST; BREAST NEOPLASMS; COHORT ANALYSIS; IMAGE PROCESSING; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

ADULT; BREAST; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAMMOGRAPHY; MIDDLE AGED; PRIMARY OVARIAN INSUFFICIENCY; PROSPECTIVE STUDIES;

EID: 84906938148     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000204     Document Type: Article

References (19)

1. Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod 2002;18:199-206.
2. Shelling AN. Premature ovarian failure. Reproduction 2010;140: 633-641.
3. Vilodre LC, Moretto M, Kohek MBF, Spritzer PM. Falência ovariana prematura: aspectos atuais. Arq Bras Endocrinol Metab 2007;51:920-929.
4. Benetti-Pinto CL, Soares PM, Magna LA, Petta CA, Santos CC. Breast density in women with premature ovarian failure using hormone therapy. Gynecol Endocrinol 2008;24:40-43.
5. Panay N, Kalu E. Management of premature ovarian failure. Best Pract Res Clin Obstet Gynaecol 2009;23:129-140.
6. Checka CM, Chun JE, Schnabel FR, Lee J, Toth H. The relationship of mammographic density and age: implications for breast cancer screening. AJR Am J Roentgenol 2012;198:292-295.
7. Harvey JA. Quantitative assessment of percent breast density: analog versus digital acquisition. Technol Cancer Res Treat 2004;3:611-616.
8. Boyd NF. Mammographic density and risk of breast cancer. Am Soc Clin Oncol Educ Book 2013;57-62. Available at: http://meetinglibrary.asco.org/ content/227-132.
9. Wolfe JN. Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol 1976;126:1130-1137.
10. Noh JJ, Maskarinec G, Pagano I, Cheung LWK, Stanczyk FZ. Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women. Breast 2006;15:20-28.
11. Junkermann H, Holst TV, Lang E, Rakov V. Influence of different HRT regimens on mammographic density. Maturitas 2004;50: 105-110.
12. Njor SH, Hallas J, Schwartz W, Lynge E, Pedersen AT. Type of hormone therapy and risk of misclassification at mammogram screening. Menopause 2011;18:171-177.
13. Anothaisintawee T, Wiratkapun C, Lerdsitthichai P, et al Risk factors of a breast cancer: a systematic review and meta-analysis. Asia Pac J Public Health 2013;25:368-387.
14. Lundstrom E, Wilezek B, von Palffy A, Soderqvist G, von Schoutz B. Mammographic breast density during hormone replacement therapy: differences according to treatment. Am J Obstet Gynecol 1999;181: 348-352.
15. Rebbeck TR, Friebel T, Wagner T, et al; PROSE Study Group. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2005;23: 7804-7810.
16. Tesic V, Kolaric B, Znaor A, Kuna SK, Brkljacic B. Mammographic density and estimation of breast cancer risk in intermediate risk population. Breast J 2013;19:71-78.
17. Lope V, Pérez-Gómez B, Sánchez-Contador C, et al; DDM-Spain. Obstetric history and mammographic density. A population-based cross-sectional study in Spain (DDm-Spain). Breast Cancer Res Treat 2012;132:1137-1146.
18. Hollenbeck S, Keely P, Seewaldt V. Mammographic density: intersection of science, the law, and clinical practice. Am Soc Clin Oncol Educ Book 2013;63-69. Available at: http://meetinglibrary.asco.org/content/226-132.
19. Hou N, Hong S, Wang W, Olopade OL, Dignam JJ, Huo D. Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight and breast density. J Natl Cancer Inst 2013;105:1365-1372.